Regulatory Pathway For “Biosimilar” Products Debated
By Donald E. Segal, Sharon D. Brooks, Marc J. Scheineson, and Julie K. Tibbets, attorneys in the Washington, D.C. office of the law firm Alston & Bird LLP.
By Donald E. Segal, Sharon D. Brooks, Marc J. Scheineson, and Julie K. Tibbets, attorneys in the Washington, D.C. office of the law firm Alston & Bird LLP.